AI assistant
DEXCOM INC — Director's Dealing 2015
Jun 3, 2015
30198_dirs_2015-06-03_fb7ee637-2b53-4efc-b646-1a5d8d620e41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-06-01
Reporting Person: DOUBLEDAY RICHARD (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-01 | Common Stock | D | 2623.0 | $71.61 | Disposed | 147945 | Direct |
Footnotes
F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
F2: Included in this number are 102,500 unvested restricted stock units, 47,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 33,333 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 5,000 of which were granted on May 31, 2013 and shall vest through May 31, 2016, and 16,667 of which were granted on March 11, 2013 and shall vest through March 11, 2016.